User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

New and emerging therapies for bone metastases in genitourinary cancers.

Primary tabs

Saylor, Philip J Armstrong, Andrew J Fizazi, Karim Freedland, Stephen Saad, Fred Tombal, Bertrand [UCL] Pienta, Kenneth

Bone metastases cause considerable morbidity and mortality among patients with genitourinary malignancies. Optimal management requires consideration of bone-targeted therapy as well as disease-specific therapy. Further research is needed to optimize the use of existing agents and to define the therapeutic potential of novel targets.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès restreint
Publication date 2013
Language Anglais
Journal information "European Urology" - Vol. 63, no.2, p. 309-20 (2013)
Peer reviewed yes
Publisher Elsevier BV ((Netherlands) Amsterdam)
issn 0302-2838
e-issn 1421-993X
Publication status Publié
Affiliations UCL - (SLuc) Service d'urologie
UCL - SSS/IREC/CHEX - Pôle de chirgurgie expérimentale et transplantation
Keywords Prostate cancer ; Bladder cancer ; Urothelial cancer ; Bone metastases ; Zoledronic acid ; Denosumab ; Radium-223
Links
Bibliographic reference Saylor, Philip J ; Armstrong, Andrew J ; Fizazi, Karim ; Freedland, Stephen ; Saad, Fred ; et. al. New and emerging therapies for bone metastases in genitourinary cancers.. In: European Urology, Vol. 63, no.2, p. 309-20 (2013)
Permanent URL http://hdl.handle.net/2078.1/120465